Not medical advice. BPC-157 is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.
BPC-157 is one of the most written-about peptides in tissue-repair research. Scientists study it for how it may influence blood-flow signals, cell migration into damaged areas, and cross-talk between the gut and other tissues in animal models.
One-paragraph overview from our research datasheet — still scientific, but faster to read than the full mechanism list below.
BPC-157 pentadecapeptide from gastric juice accelerates multi-tissue healing via VEGFR2-eNOS, FAK-paxillin, and growth hormone receptor upregulation pathways.
Peer-reviewed literature typically discusses BPC-157 in specific experimental settings. The points below reflect how the scientific community frames this compound—not as health claims, but as the research questions being asked.
Research vs. personal use: Literature describes experiments in controlled lab and animal models. This is distinct from any real-world use; our products are for laboratory research only.
Compounds in this family are frequently studied in models of tissue injury, wound closure, and how cells reorganise after damage. Research looks at cell movement, blood-vessel support, and inflammatory balance -not at replacing medical care.
Our datasheet lists mechanistic themes observed in preclinical work. These are research endpoints, not health claims. They help scientists understand and compare pathways.
Storage requirements: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation. · Learn best practices in our detailed storage guide.
Research dosing context: Literature typically discusses 200-500 μg per day · Once or twice daily, subcutaneous or intramuscular injection · IV t½ ~ 5 min; IM t½ < 30 min with linear PK in rats and dogs. IM Tmax ~6-9 min. IM bioavailability 14-19% (rat), 45-51% (dog). Stable in gastric juice >24 hrs. Metabolized via hepatic cytochrome P450; excreted renally and via bile. No human PK data formally published.
Preparation steps: Follow our detailed reconstitution guide, use the calculator tool for volume confirmation, and always verify purity with the COA reading guide.
BPC-157 is a synthetic 15-amino-acid peptide based on a fragment of Body Protection Compound (BPC), a protein naturally found in human gastric juice. Its sequence is GEPPPGKPADDAGLV. It is made in the lab by solid-phase peptide synthesis and supplied as a sterile lyophilised powder for research use only.
In preclinical research BPC-157 is studied as a cytoprotective and tissue-repair signalling peptide. Published animal studies report effects on the VEGFR2/eNOS angiogenesis (blood-vessel growth) axis, growth-hormone-receptor upregulation, nitric-oxide signalling, and gastric/gut protection. These are findings in cell and animal models, not demonstrated human effects.
In the research literature BPC-157 is used as a tool compound to study tendon, ligament, muscle, nerve and gastrointestinal tissue repair, gut-lining protection, and angiogenesis. New-U supplies it strictly for in-vitro and animal-model laboratory research; it is not for human use and no therapeutic use is implied.
BPC-157 shows consistent, reproducible repair effects across many tissues in hundreds of rodent studies, which is why it is so heavily researched. However, there are no published controlled human clinical trials, so its effectiveness in humans is unproven. It is sold as a research compound only.
In animal-model studies, measurable tissue-repair and anti-inflammatory endpoints are typically reported over days to a few weeks of repeated administration, depending on the model, injury type, route and dose. These are research timelines from preclinical studies, not human-use guidance, and study endpoints vary widely.
BPC-157 is not a scheduled or controlled substance in most jurisdictions and can be sold and purchased as a research chemical for laboratory use. It is not an approved medicine, and in 2023 the US FDA placed BPC-157 in a category restricting it from compounding pharmacies. Buyers are responsible for compliance with their local laws. New-U supplies BPC-157 for research use only.
No. BPC-157 is an investigational research peptide and is not approved by the FDA, EMA, or any other major regulator for therapeutic use in humans. It is sold strictly for preclinical and in-vitro research, not for human consumption.
Yes. The World Anti-Doping Agency (WADA) prohibits BPC-157 under class S0 (non-approved substances) on the Prohibited List, meaning it is banned both in and out of competition for athletes subject to anti-doping rules. This is one reason it is supplied for laboratory research only.
In published animal studies BPC-157 has been well tolerated with a wide margin and low reported toxicity, but there are no controlled human safety trials, so human safety is not established. It is a research compound, not a medicine; New-U makes no human-use, safety or treatment claims and supplies it for laboratory research only.
BPC-157 is not an anabolic or muscle-building agent and is not studied for hypertrophy. The research interest is in repair and recovery of connective tissue (tendon, ligament, muscle fibres) and the gut, via angiogenesis and cytoprotection — not in adding muscle mass. It is supplied for research use only.
Lyophilised BPC-157 is dissolved in bacteriostatic water (0.9% benzyl alcohol) for multi-use research vials. Concentration in mg/mL equals the vial mass in mg divided by the millilitres of diluent added — e.g. a 5 mg vial reconstituted with 2 mL gives 2.5 mg/mL, and a 10 mg vial with 2 mL gives 5 mg/mL. New-U does not provide human-use dosing guidance; this is laboratory preparation math only.
Store the lyophilised powder frozen at −20 °C until use. Once reconstituted with bacteriostatic water, keep it refrigerated at 1–6 °C and protected from light; expect roughly 5% degradation per year under those conditions, and avoid repeated freeze-thaw of the reconstituted solution.
BPC-157 has the molecular formula C₆₂H₉₈N₁₆O₂₂ and a molecular weight of 1419.53 Da, built from the 15-residue sequence GEPPPGKPADDAGLV. Pharmacokinetic work in rats and dogs reports an intramuscular elimination half-life under 30 minutes with linear kinetics, an IV half-life of roughly 5 minutes, and IM bioavailability of 14-19% (rat) and 45-51% (dog). No formal human pharmacokinetic data has been published.
BPC-157 and TB-500 are frequently paired in preclinical tissue-repair literature because they act through complementary mechanisms: BPC-157 drives the VEGFR2/eNOS angiogenesis axis and upregulates the growth-hormone receptor, while TB-500 sequesters G-actin and modulates NF-κB-driven inflammation. New-U Research Compounds supplies both as separate research-grade vials for laboratories investigating this combination. Research use only, not a human-use protocol.
New-U Research Compounds supplies BPC-157 as a lyophilised research-grade powder in sealed 10-vial packs. Every batch is independently third-party tested by Janoshik Analytics and Freedom Diagnostics to >99% purity by HPLC area normalisation, with identity confirmation by mass spectrometry, and each order ships with its batch-linked Certificate of Analysis. Direct-from-source pricing, discreet worldwide shipping, card and crypto accepted — for laboratory research use only.
It depends entirely on the peptide class being studied. For short-half-life research peptides such as BPC-157, the compound clears from the system within hours of the last administration, so it is no longer present to interact with its targets and any tissue-level changes observed in a study simply stop receiving fresh stimulus. BPC-157 is not a hormone-suppressing agent, so the literature does not describe a withdrawal or rebound effect of the kind reported with some hormonal peptides. These are observations from preclinical research models — BPC-157 is supplied for laboratory research only and is not for human use.
No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.
Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.
Other compounds researchers often read about alongside BPC-157.
Primary literature and registries for BPC-157, plus mainstream coverage of the peptide category. Research use only - not medical advice.
Databases & literature:
Peptides in the news:
Access concentration, batch info, variants, and current pricing on our shop.
Also known as: Body Protection Compound-157, BPC-15, PL 14736, PLD-116, Bepecin, Gastric Pentadecapeptide, PL-10, Stable Gastric Pentadecapeptide